Evidence map›Paper›PMID 25053704›Full record

ArticleG3 (Bethesda, Md.)2014

Position effect variegation and viability are both sensitive to dosage of constitutive heterochromatin in Drosophila.

Maria Berloco, Gioacchino Palumbo, Lucia Piacentini, Sergio Pimpinelli, Laura Fanti

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Establishment and evolution of heterochromatin.Annals of the New York Academy of Sciences · 2020
    Review
  8. Article
  9. Article
  10. Mobile genetic elements
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria BerlocoDipartimento di Biologia, Università degli studi di Bari "Aldo Moro," 70125 Bari, Italy.
Gioacchino PalumboDipartimento di Biologia, Università degli studi di Bari "Aldo Moro," 70125 Bari, Italy.
Lucia PiacentiniIstituto Pasteur, Fondazione Cenci Bolognetti and Dipartimento di Biologia e Biotecnologie "Charles Darwin," Sapienza Università di Roma, 00185 Roma, Italy.
Sergio PimpinelliIstituto Pasteur, Fondazione Cenci Bolognetti and Dipartimento di Biologia e Biotecnologie "Charles Darwin," Sapienza Università di Roma, 00185 Roma, Italy.
Laura FantiIstituto Pasteur, Fondazione Cenci Bolognetti and Dipartimento di Biologia e Biotecnologie "Charles Darwin," Sapienza Università di Roma, 00185 Roma, Italy laura.fanti@uniroma1.it.
Sapienza University of Rome · ITUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dosage effect of Y-chromosome heterochromatin on suppression of position effect variegation (PEV) has long been well-known in Drosophila. The phenotypic effects of increasing the overall dosage of Y heterochromatin have also been demonstrated; hyperploidy of the Y chromosome produces male sterility and many somatic defects including variegation and abnormal legs and wings. This work addresses whether the suppression of position effect variegation (PEV) is a general feature of the heterochromatin (independent of the chromosome of origin) and whether a hyperdosage of heterochromatin can affect viability. The results show that the suppression of PEV is a general feature of any type of constitutive heterochromatin and that the intensity of suppression depends on its amount instead of some mappable factor on it. We also describe a clear dosage effect of Y heterochromatin on the viability of otherwise wild-type embryos and the modification of that effect by a specific gene mutation. Together, our results indicate that the correct balance between heterochromatin and euchromatin is essential for the normal genome expression and that this balance is genetically controlled.

Indexed as

AnimalsDrosophilaEuchromatinFemaleHeterochromatinMaleX ChromosomeY ChromosomeEuchromatinHeterochromatinDrosophilaheterochromatinPEVviability

Identifiers

PMID25053704
PMCPMC4169164
OpenAlexW2149544970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.